Metabolism & PK Events

JoinCovanceandArcinovafor an engaging WebEx virtual symposium where experts will share insights in an interactive dialogue, exploring new approaches for optimizing your next ADME/hAME study.

Key Questions (But Bring Your Own Questions Too!)

• Why are ADME/human AME (hAME) studies required?
• What are the regulatory requirements?
• What are the pharmacy and radiosynthesis challenges?
• What are the benefits to using an integrated preclinical to clinical approach?

Presentation content for each session will be the same, and we will allow time for questions. Session Duration: 75 minutes.

• 15 September @ 10 a.m. (UK)
• 22 September @ 11 a.m. (UK)
• 29 September @ 1 p.m. (UK)

Assessment of potential drug-drug interactions (DDIs) from in vitro experiments to PBPK modeling

11 August 2020

A comparison of FDA, EMA and PMDA regulatory guidance for in vitro drug-drug interactions (DDIs) and DDI assessments

10 September 2020